معرفی
Dr. Stephen Hobson is a Lecturer in the Department of Chemistry within Newcastle University's School of Natural and Environmental Sciences, actively contributing to medicinal chemistry and organic synthesis research. His collaborative work spans multiple high-impact publications in drug discovery and green chemistry.
His research focuses on targeted cancer therapeutics (kinase/bromodomain inhibitors), antimalarial drug development, and sustainable synthesis methods. Key projects include covalent NIK inhibitors for NF-κB pathway modulation, MDM2-p53 interaction disruptors, and continuous-flow oxidation catalysis.
Recent publications (2015-2021) reveal expertise in fragment-based drug design, structure-activity relationship optimization, and flow chemistry applications. His work bridges chemical biology and translational medicine, with emphasis on selective targeting mechanisms and green chemistry principles.
No scientific awards were documented in the source material.
Hobson collaborates extensively across Newcastle's chemistry and medical research groups, evidenced by co-authorship with Professor Jane Endicott (cancer biology) and Dr. Michael Carroll (organic synthesis). While specific grant details aren't provided, his publication pattern indicates sustained funding for drug discovery and synthetic methodology projects.
His laboratory work integrates medicinal chemistry (kinase/bromodomain targets), parasitology (antimalarial compounds), and flow chemistry engineering through partnerships with chemical engineering teams.